 |
Quick Find |
 |
|
| 0 items |
|
|
|
Information |
|
|
|
|
|
Tell A Friend |
|
|
|
| Health Care Costs from Diabetes in Latin America: Implications for Health Policy pp. 191-200 |
$100.00 |
|
Authors: (Arredondo Armando, De Icaza Esteban, National Institute of Public Health, Cuernavaca, Morelos, México)
|
Abstract:
Objective: To identify health care costs and financial consequences from epidemiological changes and expected demand for health care services for diabetes in Latin America. Methods: Evaluative research based on a longitudinal study conducted in Mexico. The cost evaluation method for health care was based on instrumentation and consensus techniques. To estimate the epidemiological changes for 2009-2011, three probabilistic models were constructed according to the Box-Jenkins technique. Results: Comparing the economic impact in 2009 versus 2011 (p< 0.05), there is a 33% increase in financial requirements. The total amount for diabetes in 2010 (US dollars) will be $ 778,427,475. It include $ 343,226,541 in direct costs and $ 435,200,934 in indirect costs. The total direct costs expected are: $ 40,787,547 for the Ministry of Health (SSA), serving to uninsured population; $ 113,664,454 for insured population (Mexican Institute for Social Security–IMSS-, and Institute for Social Security and Services for State Workers-ISSSTE-); and $ 178,477,754 to users. Conclusions: If the risk factors and the different health care models remain as they are currently in the institutions analyzed, the financial consequences would be of major impact for the pockets of the users, following in order of importance, social security institutions and finally Ministry of Health. Implications for health policy include strategies addressed to health system, health providers, NGOs, and patients and their relatives. |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
Special Focus Titles |
|
|
